Becton, Dickinson and Company (BDX) fair value analysis
S&P 500 · Updated 2026-08-30
Forward Fair Value verdict
Fairly valuedBased on TickrTrends' weekly Forward Fair Value model, BDX is trading at within about 10% of estimated fair value.
- Last price
- $189.52
- Sector
- Healthcare
- 12-month range
- $145.33–$201.91
What our data shows for BDX
- Our model validated 17 trailing price-to-earnings windows for BDX, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $145.33–$201.91.
- The 14-day relative strength index sits at an overbought 72.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for BDX
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.